Here, we found that mTORC1 signaling is hyperactivated in rosacea and regulates cathelicidin via a positive feedback loop, in which cathelicidin LL37 stimulates mTORC1 signaling through binding to TLR2, thereby in turn promotes cathelicidin expression itself in human keratinocytes. The gene discussed is CAMP; the disease is rosacea.